The honest answer is longer than almost any brand tells you, and the reason is simple. The published trials ran for months before they measured anything, so any claim about week one is coming from somewhere other than the research.
Here is what each body of evidence actually measured, and when.
Skin: 12 to 16 weeks
Wunsch and Matuschka treated volunteers twice a week for 30 sessions before assessing collagen density and skin roughness, in their controlled trial published in Photomedicine and Laser Surgery in 2014. At two sessions a week, 30 sessions is fifteen weeks.
Park, Park and Jung ran their sham-controlled home mask trial for 12 weeks, five sessions a week, nine minutes each, before reporting that crow's feet improved in 86.2 percent of the active group against 16.7 percent of sham.
So the realistic window for skin is three months of consistent use. Some people notice tone or texture changes earlier, and that is worth nothing as evidence because you have also been looking at your own face daily and hoping. Skin evidence covers what those trials measured and how.
Hair: six months minimum
Hair is slower, because the follicle cycle is slower.
Lanzafame and colleagues measured at 16 weeks. Jimenez and colleagues ran 269 subjects for 26 weeks. Yoon and colleagues ran 16 weeks with sessions every other day.
Six months is the floor, and several laser caps carry unusually long return windows for exactly that reason. Judging a hair device at eight weeks is like weighing yourself hourly.
There is also a shedding detail worth knowing. Any intervention that pushes follicles from resting phase into growth phase can produce a temporary increase in shed hair first. That is not evidence of harm, and it is not evidence of benefit either. Hair evidence has the trial data.
Pain: the strange one
Pain runs on a different clock, and the shape of the curve is genuinely counterintuitive.
Stausholm and colleagues pooled 22 randomized placebo-controlled trials in knee osteoarthritis in BMJ Open in 2019. In the trials that used doses within the World Association for Laser Therapy recommendations, pain fell by 18.71 mm on a 0 to 100 scale at the end of the treatment course, then by 23.23 mm at follow-ups two to twelve weeks later.
The peak came two to four weeks after treatment finished, at 31.87 mm beyond placebo.
The effect kept building after people stopped. That has two practical consequences. Judging a device during week one is meaningless. And stopping because you have not noticed anything by the end of a course may be stopping just before the point where the trials saw the largest difference.
Trials using doses outside the recommended range did not separate from placebo at any point, which is why dosage matters more here than device price. Pain evidence covers the caveats, including why major guidelines still do not recommend it.
Muscle and strength: four weeks to see anything, twelve to be sure
Vanin and colleagues ran a 12-week strength training trial published in Lasers in Medical Science in 2016, assessing at baseline, four, eight and twelve weeks.
The group receiving light before training first separated significantly from placebo at week four, and the gap widened at eight and twelve weeks. Nothing meaningful was visible before that.
For acute effects, meaning a single session where light is used to support performance or reduce soreness the next day, the timescale is hours. For adaptation, it is months. Those are different questions with different answers. Before or after a workout goes through both.
Why nothing happens in week one
The biology sets the pace, and none of it is fast.
Dermal collagen remodelling takes weeks. Fibroblasts have to be stimulated, produce new collagen, and have it organised into the dermis before anything shows up on ultrasound or profilometry.
Hair follicles cycle over months. A follicle nudged out of resting phase still has to grow a visible terminal hair, and it does that at roughly a centimeter a month.
Joint pain responses in the meta-analysis peaked weeks after the course ended, which suggests a process that continues running after the light stops rather than an immediate analgesic effect.
None of these are switches. They are slow processes being nudged.
The two ways people get this wrong
The first is quitting at three weeks. This is the most common failure mode in the category and it guarantees you learn nothing, because no published trial measured at three weeks.
The second is the opposite. People decide it works within days, then interpret every subsequent good skin day as confirmation. That is why sham-controlled designs exist. In the mask trial above, 16.7 percent of the sham group also showed improvement on crow's feet, and those people were using a device that emitted no infrared and ran its red LEDs at a tenth intensity.
You are not immune to that, and neither are we.
More minutes will not speed it up
The instinct when nothing is happening is to run longer sessions. The evidence says that is the wrong lever.
Photobiomodulation follows a biphasic dose response, described by Huang, Chen, Carroll and Hamblin in Dose Response in 2009. Below a threshold you get nothing. Above the useful window the effect declines, and very high doses can be inhibitory.
The sham-controlled mask trial that worked ran at 10 mW/cm2 for nine minutes. The hair helmet trial that worked ran at 2.56 mW/cm2. Both are far below what a mid-range panel advertises, and both produced measurable results because the total dose and the schedule were right. Why irradiance numbers are usually wrong explains why the number on your box may not be the number in your room.
Consistency across months beats intensity in any given session.
How to actually know
Pick one objective measure before you start and stick to it.
For skin, a photograph in the same position, same light and same time of day, once a month. Not in bathroom lighting, and not after a shower.
For hair, a monthly macro photograph of the same marked area, parted the same way. Density in a fixed patch is what the trials counted.
For pain, a simple 0 to 10 score logged at the same time each day, averaged weekly. Weekly averages remove the noise that daily impressions cannot.
For strength, a repeatable lift with a fixed protocol, tested every four weeks.
Then leave the measure alone between checkpoints. Daily inspection generates noise and expectation, not data.
What would count as failure
Set the bar before you start, because it is much harder to be honest about afterwards.
For skin, no visible change in your monthly photographs after 16 weeks of five sessions a week at a consistent distance. For hair, no change in density in a marked area after six months. For pain, no movement in your weekly average score four weeks after finishing a properly dosed course.
If you hit those points with genuine adherence, the device is not working for you. That is a legitimate outcome, and the trials had non-responders too.
FAQ
Will using it twice a day get me there faster? There is no evidence for that and a mechanistic reason to doubt it. Most published protocols use three to five sessions a week, not two a day. Frequency past that point is untested at best.
Do results fade if I stop? Very probably, though this is one of the genuine gaps in the literature. Almost no trial followed participants after they stopped. For hair the realistic assumption is that gains reverse, as they do with topical treatments that need continued use.
Why do reviews say people saw changes in two weeks? Because that is what people report, not what instruments measure. Early self-reported change is the least reliable signal in this category, which is exactly why the better trials used ultrasound, profilometry and blinded hair counts instead.
Is a stronger device faster? It shortens each session, not the number of weeks. Higher irradiance means fewer minutes for the same dose. The biological timeline does not move. Dosage shows the conversion.
Sources
- Wunsch A, Matuschka K. A Controlled Trial to Determine the Efficacy of Red and Near-Infrared Light Treatment in Patient Satisfaction, Reduction of Fine Lines, Wrinkles, Skin Roughness, and Intradermal Collagen Density Increase. Photomedicine and Laser Surgery. 2014;32(2):93-100. https://journals.sagepub.com/doi/10.1089/pho.2013.3616
- Park SH, Park SO, Jung JA. Clinical study to evaluate the efficacy and safety of home-used LED and IRED mask for crow's feet. Medicine (Baltimore). 2025;104(7):e41596. https://pmc.ncbi.nlm.nih.gov/articles/PMC11835066/
- Lanzafame RJ, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers in Surgery and Medicine. 2013;45(8):487-495. https://onlinelibrary.wiley.com/doi/10.1002/lsm.22173
- Jimenez JJ, et al. Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss. American Journal of Clinical Dermatology. 2014;15(2):115-127. https://link.springer.com/article/10.1007/s40257-013-0060-6
- Yoon JS, Ku WY, Lee JH, Ahn HC. Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia. Medicine (Baltimore). 2020;99(29):e21181. https://pmc.ncbi.nlm.nih.gov/articles/PMC7373546/
- Stausholm MB, et al. Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open. 2019;9(10):e031142. https://pubmed.ncbi.nlm.nih.gov/31662383/
- Vanin AA, et al. What is the best moment to apply phototherapy when associated to a strength training program? A randomized, double-blinded, placebo-controlled trial. Lasers in Medical Science. 2016;31(8):1555-1564. https://link.springer.com/article/10.1007/s10103-016-2015-7
- Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic Dose Response in Low Level Light Therapy. Dose Response. 2009;7(4):358-383. https://pubmed.ncbi.nlm.nih.gov/20011653/